topic0
Tumour NOS [neop] 0.00394167898452
HCC [neop] 0.00286952505822
Radiofrequency Ablation [topp] 0.00525209525099
Median [spco] 0.00322151926844
Groups [idcn] 0.00435959882885
Survival [acty] 0.0150430054925
Group [idcn] 0.0136929609722
resection [topp] 0.00482922439045
Based [ftcn] 0.0036360239498
Computed Tomography [diap] 0.00296214083994
Hazard Ratio [qnco] 0.00471991732276
Prognostic [inpr] 0.00309088492142
LIVER [bpoc] 0.00668290302692
Performed [ftcn] 0.00332304063954
HEPATITIS B VIRUS [virs] 0.00291823494233
SERUM [bdsu] 0.00312069287039
Independent [idcn] 0.00657840179554
Study [mnob] 0.00827258926775
included [ftcn] 0.00288999212428
RATIO [qnco] 0.00510169157405
Nonalcoholic Fatty Liver Disease [dsyn] 0.00339760485578
Methods [inpr] 0.00687185163491
Enhanced [acty] 0.00353518137814
Compared [acty] 0.00431818377512
Cases [ftcn] 0.00374613048369
liver resection [topp] 0.00315167289632
YEARS [tmco] 0.00426409616165
Cholangiocarcinoma [neop] 0.00447704690831
YEAR [tmco] 0.00449783776637
Hepatectomy [topp] 0.00549184019517
Related [qlco] 0.00432911698349
Postoperative [tmco] 0.0055382254937
treatment [ftcn] 0.0047927171295
CIRRHOSIS [dsyn] 0.00512618302222
Curative [cnce] 0.00309061388366
Preoperative [tmco] 0.00442174967877
Levels [qlco] 0.00443676132385
Risk Factors [qnco] 0.0086311805193
Increased [qnco] 0.00347592059539
Transarterial Chemoembolization [topp] 0.00629774276672
topic1
Tumour NOS [neop] 0.00330470154827
Radiofrequency Ablation [topp] 0.00275175072911
Higher [qlco] 0.00440932017807
Groups [idcn] 0.00287944808625
Survival [acty] 0.011188229498
Group [idcn] 0.00466885588852
resection [topp] 0.00404036657421
Including [ftcn] 0.00292228627648
CI [geoa] 0.00668890511441
Hazard Ratio [qnco] 0.00329722439041
lesions [fndg] 0.0031061290002
Nonalcoholic Steatohepatitis [dsyn] 0.00281967430099
Hepatic [blor] 0.00320470165584
Hepatectomy [topp] 0.00344426388496
Criteria [inpr] 0.00349015208416
HEPATITIS B VIRUS [virs] 0.00609139723531
Independent [idcn] 0.00424688046416
investigate [ftcn] 0.00293698798505
Study [mnob] 0.00558425341858
included [ftcn] 0.00309717725274
Methods [inpr] 0.00410960217991
Compared [acty] 0.00498263526677
Cases [ftcn] 0.00576645450525
liver resection [topp] 0.00327002049191
YEARS [tmco] 0.00551966360411
Liver Transplantation [topp] 0.00427934199012
YEAR [tmco] 0.00567818286119
LIVER [bpoc] 0.00582351188686
Related [qlco] 0.00442222387233
CCA [cgab] 0.00612908150524
Postoperative [tmco] 0.00435866102153
Identified [qlco] 0.00290674148443
Portal Vein Thrombosis [dsyn] 0.00479089501193
treatment [ftcn] 0.00519603782048
Preoperative [tmco] 0.00281832011021
Risk Factors [qnco] 0.00879623280461
Pathology [bmod] 0.00298925359842
Based [ftcn] 0.00280266598324
CANCER [neop] 0.00292972636557
HCC [neop] 0.00805966264962
topic2
Tumour NOS [neop] 0.00415716005992
HCV [virs] 0.00516139238622
Transcatheter [spco] 0.00306035554583
Based [ftcn] 0.00294235238073
Survival [acty] 0.00301695208337
Group [idcn] 0.00526876318957
LIVER [bpoc] 0.00546381870041
Risk Factors [qnco] 0.00995924777416
Including [ftcn] 0.00296190238738
Laparoscopic [diap] 0.00317204080363
Important [qlco] 0.00285984376684
Nonalcoholic Steatohepatitis [dsyn] 0.00407391698542
Liver Cancer [neop] 0.00310097623251
Association [menp] 0.00371862316003
Performed [ftcn] 0.00255278494658
DIAGNOSIS [fndg] 0.00448062614147
Study [mnob] 0.0093909948067
Independent [idcn] 0.00292064109984
Nonalcoholic Fatty Liver Disease [dsyn] 0.0143041028138
Methods [inpr] 0.00411117297768
CANCER [neop] 0.00474198760887
Cases [ftcn] 0.003966110577
liver resection [topp] 0.00260477367027
chemoembolisation [topp] 0.00317061425557
YEARS [tmco] 0.00378655921212
Higher [qlco] 0.00287806722128
Cholangiocarcinoma [neop] 0.00268321917807
Liver Transplantation [topp] 0.00397643976927
Hepatectomy [topp] 0.00373804983098
Related [qlco] 0.00471951210737
Diagnosed [fndg] 0.0031014509682
Postoperative [tmco] 0.00358690492041
Odds Ratio [qnco] 0.00253584087803
treatment [ftcn] 0.00616527261474
CIRRHOSIS [dsyn] 0.00370675281
Complications [patf] 0.00257133476141
Levels [qlco] 0.00397093205839
Compared [acty] 0.00687155450264
Pathology [bmod] 0.00302746989828
Increased [qnco] 0.00454396051405
topic3
Tumour NOS [neop] 0.00516314802567
Disease-Free Survival [qnco] 0.00267394375198
Higher [qlco] 0.00297449376584
Groups [idcn] 0.00313260589606
Survival [acty] 0.0104412649049
Group [idcn] 0.00475759154883
resection [topp] 0.00395150442652
Based [ftcn] 0.00254270149751
CI [geoa] 0.0132825715474
HEPATITIS C VIRUS [virs] 0.00272252107712
Hazard Ratio [qnco] 0.00424215029644
Preoperative [tmco] 0.00253610809532
Hepatic [blor] 0.00352225412219
LIVER [bpoc] 0.0105976507079
Performed [ftcn] 0.0040557374207
SERUM [bdsu] 0.00360882712178
Independent [idcn] 0.00560075338049
Study [mnob] 0.0098537993757
Mortality [qnco] 0.00541734931996
Conclusions [idcn] 0.00507293013146
Nonalcoholic Fatty Liver Disease [dsyn] 0.00309686322218
Methods [inpr] 0.00808040650352
Compared [acty] 0.00624410319947
Cases [ftcn] 0.00430570815655
LIVER FAILURE [dsyn] 0.00341808979927
YEARS [tmco] 0.00375257424706
BLEEDING [patf] 0.00282169059294
included [ftcn] 0.00298290231488
YEAR [tmco] 0.00366893077419
Hepatectomy [topp] 0.00695231491029
Related [qlco] 0.00742960956458
CCA [cgab] 0.00422939910148
treatment [ftcn] 0.00297422847228
CIRRHOSIS [dsyn] 0.00900678340328
FIBROSIS [patf] 0.00264279264324
Cirrhotic [qlco] 0.00437945851584
Risk Factors [qnco] 0.00816501918142
CANCER [neop] 0.00270043185626
Median [spco] 0.00293144544874
Increased [qnco] 0.00410831221689
topic4
Tumour NOS [neop] 0.00518452840201
Tumors [neop] 0.00319627859661
Radiofrequency Ablation [topp] 0.00466099809748
Higher [qlco] 0.00275579295429
Including [ftcn] 0.00260548572898
Survival [acty] 0.00652153116223
Group [idcn] 0.00430635446059
resection [topp] 0.00576308358834
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00253621768818
Based [ftcn] 0.00439764578577
CI [geoa] 0.00305459881593
HEPATITIS C VIRUS [virs] 0.00320030054495
Hepatic [blor] 0.00481600133895
Criteria [inpr] 0.00430045948154
DIAGNOSIS [fndg] 0.00272396039511
Study [mnob] 0.00645864848125
Mortality [qnco] 0.00294225718738
Suggest [idcn] 0.00246018288629
Conclusions [idcn] 0.00266629305264
Methods [inpr] 0.00374000931942
Compared [acty] 0.00572623393351
Cases [ftcn] 0.00417862012346
Intrahepatic Cholangiocarcinoma [neop] 0.00392486276597
YEARS [tmco] 0.00517822386834
Liver Transplantation [topp] 0.00803575794503
YEAR [tmco] 0.00495671878099
LIVER [bpoc] 0.00343312601831
Related [qlco] 0.00269415221089
CCA [cgab] 0.00320124397357
TIME [tmco] 0.00324118294671
Identified [qlco] 0.00246973099331
treatment [ftcn] 0.00435504116098
CIRRHOSIS [dsyn] 0.00388324304294
Transplantation [topp] 0.00257207816847
Liver Cancer [neop] 0.00329873767253
Risk Factors [qnco] 0.00777665692264
Pathology [bmod] 0.00274334680091
Performed [ftcn] 0.00341907659719
CANCER [neop] 0.00360836820432
Increased [qnco] 0.00480236904838
topic5
Tumour NOS [neop] 0.00823219095187
Radiofrequency Ablation [topp] 0.009126506273
Groups [idcn] 0.00329147752802
Survival [acty] 0.0147174149628
Group [idcn] 0.00922882018225
resection [topp] 0.00652302745698
Including [ftcn] 0.0041154660032
Prognostic Factor [clna] 0.00320569981836
Hazard Ratio [qnco] 0.00311267276731
Tumour size [spco] 0.00328812335301
Hepatic [blor] 0.00377833753715
Microvascular [ftcn] 0.00467984696743
Association [menp] 0.00329764870162
Performed [ftcn] 0.00350115283204
Independent [idcn] 0.00419345632946
Invasion [fndg] 0.011546797837
LOCAL [spco] 0.00508866493178
Study [mnob] 0.00978300752359
control [qlco] 0.00338041259662
Conclusions [idcn] 0.00296365790829
Methods [inpr] 0.00385860965216
Risk Factors [qnco] 0.00815054026444
Cases [ftcn] 0.00467080261584
Intrahepatic Cholangiocarcinoma [neop] 0.00285023638851
Treated [ftcn] 0.00299618121137
YEARS [tmco] 0.00471081491152
included [ftcn] 0.0028590742218
Cholangiocarcinoma [neop] 0.00457073733576
Liver Transplantation [topp] 0.00885528085115
YEAR [tmco] 0.00531838528727
LIVER [bpoc] 0.00456563614533
Related [qlco] 0.00390224512547
Identified [qlco] 0.00361678824534
treatment [ftcn] 0.00455461351319
CIRRHOSIS [dsyn] 0.00419257811721
Curative [cnce] 0.00317219161066
Preoperative [tmco] 0.00317713147781
Compared [acty] 0.00422344986312
Tumors [neop] 0.00350925762656
Increased [qnco] 0.00388493630772
topic6
Performed [ftcn] 0.00311830057394
Important [qlco] 0.00301993209898
Higher [qlco] 0.00298984283135
DIAGNOSIS [fndg] 0.00230939832367
Including [ftcn] 0.00295547026189
Survival [acty] 0.00732167219018
Group [idcn] 0.00389531538069
resection [topp] 0.00280390982411
Based [ftcn] 0.00515360703656
CI [geoa] 0.00243736468731
HEPATITIS C VIRUS [virs] 0.00293979781372
Hazard Ratio [qnco] 0.00228279494009
LIVER [bpoc] 0.00472558438836
Criteria [inpr] 0.00530888903982
HEPATITIS B VIRUS [virs] 0.00529038374755
Independent [idcn] 0.00266544166167
Study [mnob] 0.0105182000329
Mortality [qnco] 0.0106923495597
OBESITY [dsyn] 0.00262735806328
Conclusions [idcn] 0.00311165642382
Methods [inpr] 0.00509626525569
METABOLIC SYNDROME [dsyn] 0.00287484309375
Compared [acty] 0.00350248717867
Cases [ftcn] 0.00361576720636
Hepatitis B, Chronic [dsyn] 0.00242768768257
YEARS [tmco] 0.00508341483193
included [ftcn] 0.00225588796602
YEAR [tmco] 0.00456250181106
Hepatectomy [topp] 0.00309179730914
LIVER CIRRHOSIS [dsyn] 0.00282614405425
Related [qlco] 0.00564027481436
CCA [cgab] 0.00254664542108
Identified [qlco] 0.00305595923428
Tumour NOS [neop] 0.00277310255558
treatment [ftcn] 0.00695058510449
CIRRHOSIS [dsyn] 0.00452200291774
Risk Factors [qnco] 0.0114349911076
Association [menp] 0.00247524072977
CANCER [neop] 0.00273627199812
Increased [qnco] 0.0033555788243
topic7
Early Recurrence [fndg] 0.00259261960335
Tumour NOS [neop] 0.00375093534719
Radiofrequency Ablation [topp] 0.0026304427843
Cases [ftcn] 0.00503793624332
Groups [idcn] 0.00360451515963
Survival [acty] 0.00735920024275
Group [idcn] 0.00811542553241
resection [topp] 0.0107689025932
FIBROSIS [patf] 0.00269965951042
HEPATITIS C VIRUS [virs] 0.00346354716863
Nonalcoholic Steatohepatitis [dsyn] 0.00296219294154
Hepatic [blor] 0.00644415702064
LIVER [bpoc] 0.0087390294969
Performed [ftcn] 0.00361808628848
HEPATITIS B VIRUS [virs] 0.00568272636541
Independent [idcn] 0.00526011325803
Study [mnob] 0.00950046456682
Conclusions [idcn] 0.00400990666269
Nonalcoholic Fatty Liver Disease [dsyn] 0.00472113217462
Methods [inpr] 0.00522908893417
Risk Factors [qnco] 0.0105496983684
Median [spco] 0.00507102873493
Intrahepatic Cholangiocarcinoma [neop] 0.00320627464322
Treated [ftcn] 0.00253768579613
Hepatitis B, Chronic [dsyn] 0.00379824515085
YEARS [tmco] 0.00806238838847
Mutations [genf] 0.00270263155128
Higher [qlco] 0.00379338882474
YEAR [tmco] 0.00333575026184
Hepatectomy [topp] 0.00428944748809
Related [qlco] 0.00842034751486
Identified [qlco] 0.00390128379707
Odds Ratio [qnco] 0.00343586799515
treatment [ftcn] 0.00664917440486
CIRRHOSIS [dsyn] 0.00548775855464
Increased [qnco] 0.00567899400553
Levels [qlco] 0.00276458341305
Compared [acty] 0.00536734879303
Curative [cnce] 0.00390253034155
HCC [neop] 0.00325165970563
topic8
Early Recurrence [fndg] 0.00261397516856
Tumour NOS [neop] 0.007441298731
Radiofrequency Ablation [topp] 0.00305147287322
Transcatheter [spco] 0.00277923351428
Present [qnco] 0.0032323007031
Survival [acty] 0.00490967463951
Group [idcn] 0.00406345600834
resection [topp] 0.00623964500411
CI [geoa] 0.00364970861672
HEPATITIS C VIRUS [virs] 0.00318236497209
Hepatectomy [topp] 0.00311453706234
Performed [ftcn] 0.00359198314607
HEPATITIS B VIRUS [virs] 0.00294849439456
Independent [idcn] 0.00471664433833
Study [mnob] 0.00714604384175
control [qlco] 0.00346606128806
DIAGNOSIS [fndg] 0.00281731732121
rights [qlco] 0.00258530626646
Nonalcoholic Fatty Liver Disease [dsyn] 0.00428412148192
Methods [inpr] 0.0039614199878
Risk Factors [qnco] 0.00632805931869
Cases [ftcn] 0.00514736312772
Arterial [bpoc] 0.00260724148538
Mutations [genf] 0.00355436790585
-- Gastric Cancer [neop] 0.0032116741363
Cholangiocarcinoma [neop] 0.00343115844711
Induced [ftcn] 0.00267561408649
YEAR [tmco] 0.00316543978604
LIVER [bpoc] 0.00721726869264
Related [qlco] 0.00443475135796
Genotype [orga] 0.00277593120933
Identified [qlco] 0.00308063524527
Odds Ratio [qnco] 0.00271792175615
treatment [ftcn] 0.0058947744399
CIRRHOSIS [dsyn] 0.00254977779276
Reserve [acty] 0.00283672509663
Compared [acty] 0.00322434430054
LARGE [qnco] 0.00475068582145
Pathology [bmod] 0.00292593028879
Tumors [neop] 0.00338996724265
topic9
Tumour NOS [neop] 0.00315237316011
HCV [virs] 0.00500361639967
Median [spco] 0.00249260925124
Based [ftcn] 0.00355678703356
Survival [acty] 0.00505102943031
Group [idcn] 0.00352623755743
Phase [tmco] 0.00246424815895
Imaging, Magnetic Resonance [diap] 0.00349043749768
CI [geoa] 0.00252721609483
Hazard Ratio [qnco] 0.00575734266394
Levels [qlco] 0.00252426245672
Reserve [acty] 0.00262319729902
Association [menp] 0.00324838353337
Performed [ftcn] 0.00255482636629
HEPATITIS B VIRUS [virs] 0.00356311850677
Independent [idcn] 0.00330387427789
Imaging [diap] 0.00287551548914
Study [mnob] 0.00946682492178
Mortality [qnco] 0.0032458386491
Conclusions [idcn] 0.00350244025911
Methods [inpr] 0.00570441929852
Enhanced [acty] 0.00325225353649
Risk Factors [qnco] 0.0151479953341
Cases [ftcn] 0.00368399448781
Including [ftcn] 0.00305793701648
YEARS [tmco] 0.0065439638769
Higher [qlco] 0.00246534221194
Women [popg] 0.00272412953043
Cholangiocarcinoma [neop] 0.00281698787263
YEAR [tmco] 0.0059841627426
LIVER [bpoc] 0.00513395311193
TIME [tmco] 0.00266210126386
Identified [qlco] 0.00320586511966
Odds Ratio [qnco] 0.00277581281953
treatment [ftcn] 0.00567172549432
CIRRHOSIS [dsyn] 0.00807405040054
Liver Cancer [neop] 0.00321249451471
Compared [acty] 0.00356159453721
CANCER [neop] 0.00539507562957
Increased [qnco] 0.00266354276198
